HSBC Holdings’s LifeMD LFMD Stock Holding History

HSBC Holdings’s Portfolio LFMD Stock Details LFMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-99,000	Closed	-$815K	–	3155
2023 Q4	$815K	Buy	+99,000	New	+$712K	﹤0.01%	1858

Other funds holding LFMD

DSCM

Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HSBC Holdings's LFMD Position: Q1 2024 in Review

HSBC Holdings sold out of LifeMD (LFMD) in Q1 2024, closing a stake of 99,000 shares — an estimated $815K sold.

HSBC Holdings first reported a position in LFMD in Q4 2023 and held it in 1 quarter. The position peaked at $815K in Q4 2023. 89 funds tracked by Wall St. Rank hold LFMD as of Q1 2024.

HSBC Holdings reported no remaining LifeMD position as of Q1 2024 after selling out during the quarter.
HSBC Holdings sold 99,000 LifeMD shares in Q1 2024, an estimated $815K.
HSBC Holdings first reported a position in LifeMD in Q4 2023 and held it in 1 quarter.
HSBC Holdings's LifeMD position peaked at $815K in Q4 2023.
89 funds tracked by Wall St. Rank held LifeMD as of Q1 2024.

Based on HSBC Holdings's 13F filing for Q1 2024, filed 15 May 2024.